BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9724383)

  • 21. Radio-guided surgery: advantages of a new portable γ-camera (Sentinella) for intraoperative real time imaging and detection of sentinel lymph nodes in cutaneous malignancies.
    Stoffels I; Poeppel T; Boy C; Mueller S; Wichmann F; Dissemond J; Schadendorf D; Rosenbaum-Krumme S; Klode J
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):308-13. PubMed ID: 21429042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of melanoma lesions using ¹³¹I-IMBA obtained by electrophilic substitution of ¹³¹I for metal organic substituent - a preliminary communication.
    Janczak M; Nejc D; Bieńkiewicz M; Płachcińska A; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2010; 13(2):70-5. PubMed ID: 21598230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited sensitivity of iodine-123-2-hydroxy-3-iodo-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl ] benzamide whole-body scintigraphy in patients with malignant melanoma: a comparison with thallium-201 imaging.
    Brenner W; Klomp HJ; Bohuslavizki KH; Szonn B; Kampen WU; Henze E
    Eur J Nucl Med; 1999 Dec; 26(12):1567-71. PubMed ID: 10638408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and biologic evaluation of a novel radioiodinated benzylpiperazine, 123I-MEL037, for malignant melanoma.
    Pham TQ; Berghofer P; Liu X; Greguric I; Dikic B; Ballantyne P; Mattner F; Nguyen V; Loc'h C; Katsifis A
    J Nucl Med; 2007 Aug; 48(8):1348-56. PubMed ID: 17631542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
    Strobel K; Dummer R; Husarik DB; Pérez Lago M; Hany TF; Steinert HC
    Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
    Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of positron emission tomography for the detection of melanoma metastases.
    Holder WD; White RL; Zuger JH; Easton EJ; Greene FL
    Ann Surg; 1998 May; 227(5):764-9; discussion 769-71. PubMed ID: 9605668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models.
    Viallard C; Perrot Y; Boudhraa Z; Jouberton E; Miot-Noirault E; Bonnet M; Besse S; Mishellany F; Cayre A; Maigne L; Rbah-Vidal L; D'Incan M; Cachin F; Chezal JM; Degoul F
    Eur J Dermatol; 2015; 25(1):29-35. PubMed ID: 25548082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
    Clark PB; Soo V; Kraas J; Shen P; Levine EA
    Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED; Farnetani F; Pellacani G; Constantin MM
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of melanoma with radiolabelled monoclonal antibody fragments and iodoamphetamine.
    Liewendahl K; Kairento AL; Pyrhönen S; Franssila K; Asko-Seljavaara S; Lindroth L; Virkkunen P; Launes J
    Eur J Nucl Med; 1986; 12(7):359-62. PubMed ID: 3792368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visualizing ocular melanoma using iodine-123-N-(2-diethylaminoethyl)4-iodobenzamide SPECT.
    Everaert H; Bossuyt A; Flamen P; Mertens J; Franken PR
    J Nucl Med; 1997 Jun; 38(6):870-3. PubMed ID: 9189131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
    Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of novel radioiodinated nicotinamides for malignant melanoma.
    Liu X; Pham TQ; Berghofer P; Chapman J; Greguric I; Mitchell P; Mattner F; Loc'h C; Katsifis A
    Nucl Med Biol; 2008 Oct; 35(7):769-81. PubMed ID: 18848662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [123I]IBZM uptake in metastatic melanoma.
    Maffioli LS; Mascheroni L; Clemente C; Baldini M; Castellani MR
    J Nucl Biol Med (1991); 1993 Mar; 37(1):18-20. PubMed ID: 8329472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [123I-alpha-methyltyrosine scintigraphy in malignant melanoma].
    Steinert H; Böni R; Huch-Böni RA; Capaul R; von Schulthess GK; Westera G
    Nuklearmedizin; 1997 Mar; 36(2):36-41. PubMed ID: 9148271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT.
    Akcali C; Zincirkeser S; Erbagcý Z; Akcali A; Halac M; Durak G; Sager S; Sahin E
    J Int Med Res; 2007; 35(4):547-53. PubMed ID: 17697533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52.
    Mier W; Kratochwil C; Hassel JC; Giesel FL; Beijer B; Babich JW; Friebe M; Eisenhut M; Enk A; Haberkorn U
    J Nucl Med; 2014 Jan; 55(1):9-14. PubMed ID: 24277756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioiodinated methylene blue for melanoma targeting: chemical characterisation and tumour selectivity of labelled components.
    Blower PJ; Clark K; Link EM
    Nucl Med Biol; 1997 May; 24(4):305-10. PubMed ID: 9257328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.